Is ferroportin-hepcidin signaling altered in restless legs syndrome?

Journal of the Neurological Sciences

Volumn 247, Issue 2, 2006, Pages 173-179

  Clardy, Stacey L ^a   Wang, Xinsheng ^a   Boyer, Philip J ^b   Earley, Christopher J ^c   Allen, Richard P ^c   Connor, James R ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia disorders; Cerebrospinal fluid (CSF); Iron; Laser capture microdissection (LCM); Movement disorders; Neuromelanin; Putamen

Indexed keywords

HEPCIDIN; IRON; IRON BINDING PROTEIN; NEUROMELANIN;

ADULT; AGED; ARTICLE; BRAIN VENTRICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHOROID PLEXUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPENDYMA CELL; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IRON KINETICS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PUTAMEN; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CATION TRANSPORT PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; MALE; MICRODISSECTION; MIDDLE AGED; POSTMORTEM CHANGES; RESTLESS LEGS SYNDROME; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 33748433837     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.04.008     Document Type: Article

References (35)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 2 (2003) 101-119
2. Phillips B., Young T., Finn L., Asher K., Hening W.A., and Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 160 14 (2000) 2137-2141
3. Rothdach A.J., Trenkwalder C., Haberstock J., Keil U., and Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 54 5 (2000) 1064-1068
4. Allen R.P., and Earley C.J. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 1 (2000) 11-19
5. Labuda M. Epidemiology, family patterns and genetics of restless legs syndrome in RLS Foundation Conference Washington, DC (1997)
6. Connor J.R., Boyer P.J., Menzies S.L., Dellinger B., Allen R.P., Ondo W.G., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61 (2003) 304-309
7. Allen R.P., Barker P.B., Wehrl F., Song H.K., and Earley C.J. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56 2 (2001) 263-265
8. Clardy S., Earley C.J., Allen R.P., Beard J.L., and Connor J.R. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med 147 2 (2006) 67-73
9. Earley C., Connor J.R., Beard J.L., Clardy S.L., and Allen R.P. CSF ferritin and restless legs syndrome: effects of different clinical phenotypes. Sleep 28 9 (2005) 1069-1075
10. Mizuno S., Mihara T., Miyaoka T., Inagaki T., and Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 14 1 (2005) 43-47
11. Connor J.R., Wang X.S., Patton S.M., Menzies S.L., Troncoso J.C., Earley C.J., et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 62 9 (2004) 1563-1567
12. Pietrangelo A., and Trautwein C. Mechanisms of disease: the role of hepcidin in iron homeostasis - implications for hemochromatosis and other disorders. Nat Clin Pract Gastroenterol Hepatol 1 1 (2004) 39-45
13. Dallalio G., Fleury T., and Means R.T. Serum hepcidin in clinical specimens. Br J Haematol 122 6 (2003) 996-1000
14. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A (2001)
15. Nicolas G., Bennoun M., Porteu A., Mativet, Beaumont C., Grandchamp B., et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A (2002)
16. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 10 (2002) 3776-3781
17. Ganz T. Hepcidin - a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 18 2 (2005) 171-182
18. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 9 (2004) 1271-1276
19. Viatte L., Lesbordes-Brion J.C., Lou D.Q., Bennoun M., Nicolas G., Kahn A., et al. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 105 12 (2005) 4861-4864
20. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275 26 (2000) 19906-19912
21. Roy C.N., and Andrews N.C. Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 10 20 (2001) 2181-2186
22. Courselaud B., Pigeon C., Inoue Y., Inoue J., Gonzalez F.J., Leroyer P., et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 277 43 (2002) 41163-41170
23. Knutson M.D., Oukka M., Koss L.M., Aydemir F., and Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102 5 (2005) 1324-1328
24. Zoller H., Theurl I., Koch R., Kaser A., and Weiss G. Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Diseases 29 3 (2002) 488-497
25. Nemeth E., Tuttle MS., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 5704 (2004) 2090-2093
26. Wu L.J., Leenders A.G., Cooperman S., Meyron-Holtz E., Smith S., Land W., et al. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001 1-2 (2004) 108-117
27. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66 6 (2001) 1198-1207
28. Moos T., and Morgan E.H. Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20 1 (2000) 77-95
29. Jensen K. Ceruloplasmin in human cerebrospinal fluid. Acta Neurol Scand 39 (1963) 237-241
30. Earley C.J., Connor J.R., Beard J.L., Malecki E.A., Epstein D.K., and Allen R.P. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54 8 (2000) 1698-1700
31. Siddappa A.J., Rao R.B., Wobken J.D., Casperson K., Leibold E.A., Connor J.R., et al. Iron deficiency alters iron regulatory protein and iron transport protein expression in the perinatal rat brain. Pediatr Res 53 5 (2003) 800-807
32. Connor J.R., Menzies S.L., Burdo J.R., and Boyer P.J. Iron and iron management proteins in neurobiology. Pediatr Neurol 25 2 (2001) 118-129
33. Moos T. Brain iron homeostasis. Dan Med Bull 49 4 (2002) 279-301
34. Brookes M.J., Sharma N.K., Tselepis C., and Iqbal T.H. Serum pro-hepcidin: measuring active hepcidin or a non-functional precursor?. Gut 54 1 (2005) 169-170
35. Kulaksiz H., Gehrke S.G., Janetzko A., Rost D., Bruckner T., Kallinowski B., et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53 5 (2004) 735-743